Article
Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.
American journal of Alzheimer's disease and other dementias - 1 Mar 2015
Braga Ianna Lacerda Sampaio, Silva Patricia Natalia, Furuya Tatiane Katsue, Santos Leonardo Caires, Pires Belisa Caldana, Mazzotti Diego Robles, Bertolucci Paulo Henrique, Cendoroglo Maysa Seabra, Smith Marília Cardoso
Abstract excerpt
The loss of cholinergic transmission is considered to be an important cause of Alzheimer's disease (AD). Treatment with acetyl cholinesterase inhibitors (ChEIs) shows benefits; however, great heterogeneity has been observed in patient responses. We evaluated apolipoprotein E (APOE) and α7 nicotinic receptor (CHRNA7) single-nucleotide polymorphisms (SNPs) and associated these SNPs with pharmacological responses to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
